Inhibition of AXL dependent non-professional efferocytosis sensitizes pancreatic cancer to immune checkpoint blockade
Joon Y. Park, Tyler R. McCaw, Hoang Dao, Timothy R. Donahue, Joe Crompton, Erina Vlashi, Mark D. Girgis
This study shows that inhibiting AXL in pancreatic cancer cells enhances immune checkpoint therapy by blocking non-professional efferocytosis and increasing CD8 T cell infiltration.
bioRxiv · Aug 12, 2025 · PreprintCancer Biology